Medically reviewed by Jay N. Yepuri, MD PBC is a chronic liver disease that damages bile ducts and can lead to liver failure. You can get treatment for PBC to slow disease progression and manage ...

SOUTH SAN FRANCISCO, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel ...

The Friends of the PBC Foundation hosted their first U.S.-based PBC Patient Conference, bringing together patients, families, ...

The liver donors and recipients involved in Utah's first pediatric paired liver exchange met for the first time on Friday.

Freddie Bentley has revealed he was diagnosed with liver failure aged 24 after he was rushed to hospital with yellow pupils ...

Ipsen’s elafibranor has shown promise as a treatment for primary sclerosing cholangitis (PSC), a rare liver disease that currently has no approved treatment options. Results from the phase 2 ELMWOOD ...

With transplant waiting lists hitting record highs, 29-year-old Katie Howard faces years of putting her life on hold ...

Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "Primary Biliary Cholangitis Market Opportunities and Strategies to 2034" report has been added to ResearchAndMarkets.com's offering. This report ...

Elafibranor showed a favorable safety profile and demonstrated dose-dependent efficacy over 12 weeks for people living with PSC, a rare liver disease that currently has no approved treatment options ...

Families are celebrating a first in Utah -- the state’s first pediatric paired exchange and liver transplant that helped save the lives of two young children. The two met on Friday, Sept. 26, for the ...